Recombinant Insulin Human AF for upstream processes
Our recombinant insulin is a key component in serum free growth media for mammalian cells.
Annual Report 2019
Every year, we at Novo Nordisk Pharmatech publish a single, integrated report on our performance.
Read the Annual Report 2019 here and learn more about our accomplishments and results, our way of doing business and our financial statements.
